Feasibility of Addressing Sexual Dysfunction in Women with Breast and Gynecologic Cancers with a Novel Mobile Application

This study is looking at how a mobile app called Rosy might help women who have experienced breast or gynecologic (cancers of the female reproductive organs like the uterus, ovaries, or cervix) cancers and are dealing with sexual dysfunction. The study will provide you with a six-month subscription to the Rosy app, which offers coaching and a community forum. Researchers want to see if using the Rosy app can reduce personal distress related to sex and improve sexual function. You can join if you are a woman aged 18 or older with a current or past diagnosis of breast or gynecologic cancer and agree to use the app and complete surveys. The study plans to enroll 20 participants.

Study design
This is an interventional study, meaning participants will receive a specific intervention (the Rosy app). It plans to include 20 participants.
What's involved
You would use the Rosy mobile application for six months and complete surveys at the beginning and end of this period.
Compensation
Not stated in the trial record.
Follow-up
Your sexual function and distress will be assessed at the beginning of the study and again after six months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06694142

Feasibility of Addressing Sexual Dysfunction in Women with Breast and Gynecologic Cancers with a Novel Mobile Application

Not Yet Recruiting
NAAges 18+InterventionalSupportive care
The University of Texas Health Science Center, Houston
~20 participants
Updated 2024-11-19 on ClinicalTrials.gov
What's tested:Rosy app

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in sex related personal distress as assessed by the Female Sexual Function Index (FSFI)
Measured over Baseline, 6 months
+1 more outcome measured
Sexual Dysfunction
1 sites across 1 states
Texas1
  • Lavanya P Parsons, MD · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center, Houston

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patient with a current or historic diagnosis of breast cancer or gynecologic cancer (uterine ovarian, fallopian tube, peritoneal, cervical, vulva, or vaginal cancers)
Agree to participate in the study with completion of survey and use of ROSY mobile application

Exclusion

Currently pregnant
Non-English speaking (ROSY is currently is only available is in English).
  • Change in sex related personal distress as assessed by the Female Sexual Function Index (FSFI)Baseline, 6 months

    FSFI is a 19-item instrument that measures 6 domains of sexual function: Desire, Arousal, Lubrication, Orgasm, Satisfaction, and Pain. This uses a Likert-type scale, with scores ranging from 0 to 5, except for questions 1, 2, 13, and 16, which are scored from 1 to 5. The total score ranges from 2.0 to 36.0, with higher scores indicating better functioning.

  • Change in sexual dysfunction as assessed by the Social Determinants of Health (SDOH) questionnaireBaseline, 6 months

    score ranges from 0 to 10, higher score showing worse outcome